drugset / Trial / NCT00244192
Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia
Phase 2
Completed
16 enrolled
Center for Integrated Rehabilitation and Organ Failure Horn
Centocor, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether infliximab is effective on fat-free mass in the treatment of patients with moderate to severe COPD suffering from cachexia.
Timeline
- Start
- 2003-10
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | 5 mg/kg | — |